ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 876,08
-0,03%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Xeris Biopharma Holdings Inc (XERS)

  7. Xeris Biopharma Holdings Inc (XERS) Actualités

XERS Xeris Biopharma Holdings Inc

1,93
0,07 (3,76%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Xeris Biopharma Holdings Inc XERS NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,07 3,76% 1,93 06:00:11
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,90 1,84 1,93 1,89 1,86
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
02/5/202413:00BWXeris Biopharma to Report First Quarter 2024 Financial..
03/4/202422:05BWXeris Pharmaceuticals Announces Inducement Grants Under..
02/4/202413:00BWXeris Biopharma to Participate in the 23rd Annual Needham..
06/3/202422:19EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/3/202422:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
06/3/202413:27EDGAR2Form 8-K - Current report
06/3/202413:02BWXeris Biopharma Reports Fourth Quarter and Full Year 2023..
06/3/202413:00BWXeris Refinances Its $150M Senior Secured Term Loan Facility..
28/2/202413:00BWXeris Biopharma to Report Fourth Quarter and Full Year 2023..
05/2/202413:00BWXeris to Present at the Oppenheimer 34th Annual Healthcare..
31/1/202423:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202416:12DJNXeris Biopharma Shares Climb 12% on Amgen License Agreement
10/1/202414:53DJNXeris Biopharma Reaches License Agreement With Amgen On..
10/1/202414:00BWXeris Biopharma Enters Into an Exclusive Worldwide License..
05/1/202422:05BWXeris Pharmaceuticals Announces Inducement Grants Under..
04/1/202413:09EDGAR2Form 8-K - Current report
04/1/202413:00BWXeris Biopharma Updates Its Outlook for 2023
27/12/202313:00BWXeris Biopharma to Present at the 42nd Annual J.P. Morgan..
21/11/202322:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202322:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202313:20EDGAR2Form 8-K - Current report
09/11/202313:00BWXeris Biopharma Reports Third Quarter 2023 Financial Results
16/10/202313:12EDGAR2Form 8-K - Current report
16/10/202313:00BWXeris Biopharma Raises Full-Year Financial Guidance and..
29/9/202322:55EDGAR2Form 8-K - Current report
27/9/202314:11EDGAR2Form 8-K - Current report
27/9/202314:00BWXeris Biopharma Announces Private Convertible Note Exchange..
14/9/202322:05BWXeris to Participate in the 2023 Cantor Global Healthcare..
28/8/202313:00BWXeris to Participate at the H.C. Wainwright 25th Annual..
08/8/202322:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202313:23EDGAR2Form 8-K - Current report
08/8/202313:00BWXeris Biopharma Reports Second Quarter 2023 Financial..
01/8/202313:00BWXeris Biopharma to Report Second Quarter 2023 Financial..
31/7/202313:00BWXeris Ships One Millionth Gvoke® Unit
28/6/202322:28EDGAR2Form 8-K - Current report
21/6/202313:00BWXeris Biopharma Announces First Participant Dosed in a Phase..
01/6/202313:00BWXeris Biopharma to Participate at the Jefferies Healthcare..
09/5/202313:00BWXeris Biopharma Reports First Quarter 2023 Financial Results

Dernières Valeurs Consultées

NASDAQ
XERS
Xeris Biopharma
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés